In human papilloma virus (HPV)-positive cervical cancer cells, such as HeLa cells, HPV E6 oncoprotein selectively targets p53 for degradation via ubiquitin-protein ligase E6-AP instead of Mdm2 [35], which is the main mediator of p53 degradation under normal growth conditions. Here, TP53 is linked to cervical carcinoma.